KyDo Therapeutics
Dortmund, DE · 2 known investors
Find your way into KyDo Therapeutics
Sign up to see every warm intro you have to KyDo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the KyDo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
KyDo Therapeutics is a preclinical-stage biotechnology company developing novel covalent-allosteric small molecule inhibitors intended to become best-in-class oncology drugs. Its lead programs target hard-to-treat cancers such as glioblastoma, and the company is based in Dortmund, Germany.
Investors · 2
In the news
Frequently asked questions
- What does KyDo Therapeutics do?
- KyDo Therapeutics is a preclinical-stage biotechnology company developing novel covalent-allosteric small molecule inhibitors intended to become best-in-class oncology drugs. Its lead programs target hard-to-treat cancers such as glioblastoma, and the company is based in Dortmund, Germany.
- Who are KyDo Therapeutics's investors?
- KyDo Therapeutics's investors include i&i Biotech Fund, Khanu.
- Where is KyDo Therapeutics headquartered?
- KyDo Therapeutics is headquartered in Dortmund, DE.
